|
|
| | PC5-VC-PAB-MMAE Basic information |
| Product Name: | PC5-VC-PAB-MMAE | | Synonyms: | PC5-VC-PAB-MMAE;Perfluorophenyl 5-(((S)-1-(((S)-1-((4-((5S,8S,11S,12R)-11-((S)-sec-butyl)-12-(2-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradecyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoate | | CAS: | 2922216-98-4 | | MF: | C69H99F5N10O15 | | MW: | 1403.58 | | EINECS: | | | Product Categories: | | | Mol File: | 2922216-98-4.mol |  |
| | PC5-VC-PAB-MMAE Chemical Properties |
| Boiling point | 1341.3±65.0 °C(predicted) | | density | 1.243±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 13.29±0.70(predicted) | | form | Solid | | color | White to off-white |
| | PC5-VC-PAB-MMAE Usage And Synthesis |
| Uses | PC5-VC-PAB-MMAE consists the ADCs linker (PC5-VC-PAB) and potent tubulin inhibitor (MMAE). PC5-VC-PAB-MMAE is a agent-linker conjugate for ADC[1]. | | References | [1] Zhaohui LI, et al. Anti-cd39 antibody-drug conjugate and use thereof. China, WO2023051712. 2023-04-06. |
| | PC5-VC-PAB-MMAE Preparation Products And Raw materials |
|